The increased expression of CYP24A1 was demonstrated to be correlated with the advanced stages of prostate, colon, lung and breast cancers, stimulating resistance to vitamin D-mediated therapy [57,61,68,69,70,71,72]. The gene discussed is CYP24A1; the disease is breast carcinoma.